Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F15%3A10296710" target="_blank" >RIV/00216208:11140/15:10296710 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00669806:_____/15:10296710

Výsledek na webu

<a href="http://onlinelibrary.wiley.com/doi/10.1111/dth.12271/abstract" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/dth.12271/abstract</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/dth.12271" target="_blank" >10.1111/dth.12271</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis

Popis výsledku v původním jazyce

A case is descibed o severe acute hepatitis in 47-year-old woman with chronic psoriasis and psoriatic arthritis treated with infliximab. Although clinical, serological and laboratory results werre compatible with acute EBV hepatitis, it was difficult todifferentiate between EBV infection and other non-infectious causes of hepatitis. The patient gradually developed chronic hepatitis with liver steatosis and efficient treatment with adalimumab had to be stopped. This case presents an uncommon complication that may arise from the use of biologic therapy and calls for caution in long-term management of psoriatic patients with internal comorbidities.

Název v anglickém jazyce

Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis

Popis výsledku anglicky

A case is descibed o severe acute hepatitis in 47-year-old woman with chronic psoriasis and psoriatic arthritis treated with infliximab. Although clinical, serological and laboratory results werre compatible with acute EBV hepatitis, it was difficult todifferentiate between EBV infection and other non-infectious causes of hepatitis. The patient gradually developed chronic hepatitis with liver steatosis and efficient treatment with adalimumab had to be stopped. This case presents an uncommon complication that may arise from the use of biologic therapy and calls for caution in long-term management of psoriatic patients with internal comorbidities.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FO - Dermatovenerologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Dermatologic Therapy

ISSN

1396-0296

e-ISSN

—

Svazek periodika

28

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

4

Strana od-do

369-372

Kód UT WoS článku

000368530500012

EID výsledku v databázi Scopus

2-s2.0-84955185123